The biotech bi-weekly: a multi-modal cancer diagnostic panel for precision oncology and a promising preclinical macular degeneration study

Written by Beatrice Bowlby (Digital Editor)
Cancer research Cell and tissue biology News PCR and sequencing

From expanding an infectious disease assay portfolio to pioneering an imaging system to enhance space biology, here are the products, partnerships and publications that have been announced over the last 2 weeks. Products 1Cell.Ai, formerly OneCell Diagnostics, launches OncoIncytes integrating multi-modal data for precision oncology OneCell Diagnostics (Mumbai, India) recently announced its launch of OncoIncytes, a comprehensive multi-modal cancer diagnostic panel that integrates multiple types of data including circulating tumor DNA, circulating tumor cells at single-cell resolution, RNA transcriptomics and proteomics. Marking its evolution from a genomics-based diagnostic company to an AI-powered leader in precision oncology, the firm is also...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!